Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-05

Clinical Trial Update: Effects of Denosumab on Periprosthetic Bone After Total Hip Arthroplasty [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports on the effects of denosumab on periprosthetic bone after total hip arthroplasty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Denosumab (denosumab)

Snippet

Sponsor: Hans Mallmin | Conditions: Osteoarthritis, Hip, Ambulation Difficulty | Phase 2 | Status: COMPLETED